We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$39.9B
AUM Growth
+$1.35B
(+3.5%)
Cap. Flow
-$64.9M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
2,910
New
487
Increased
855
Reduced
1,229
Closed
318
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$379M |
| 2 |
NVIDIA
NVDA
|
+$346M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 4 |
PayPal
PYPL
|
+$328M |
| 5 |
Advanced Micro Devices
AMD
|
+$279M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$461M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$406M |
| 3 |
Snap
SNAP
|
+$379M |
| 4 |
Analog Devices
ADI
|
+$283M |
| 5 |
AT&T
T
|
+$280M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Healthcare | 22.86% |
| 3 | Industrials | 9.26% |
| 4 | Financials | 8.76% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
WSFS Financial
WSFS
$4.12B
| $316K | ﹤0.01% |
6,300
-1,300
| -17% | -$68.1K |
|
2127
Evolus
EOLS
$385M
| $315K | ﹤0.01% |
48,400
-33,200
| -41% | -$228K |
|
2128
Riverview Bancorp
RVSB
$107M
| $315K | ﹤0.01% |
40,900
-900
| -2% | -$6.84K |
|
|
GOL
2129
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $313K | ﹤0.01% |
51,771
-136,200
| -72% | -$869K |
|
2130
WPP
WPP
$4.36B
| $310K | ﹤0.01% |
4,100
-5,500
| -57% | -$392K |
|
|
ZYNE
2131
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $310K | ﹤0.01% |
107,500
-67,800
| -39% | -$251K |
|
2132
GXO Logistics
GXO
$5.77B
| $309K | ﹤0.01% |
3,400
-10,000
| -75% | -$899K |
|
|
MSB
2133
Mesabi Trust
MSB
$289M
| $309K | ﹤0.01% |
11,700
+1,516
| +15% | +$40.6K |
|
2134
Tonix Pharmaceuticals
TNXP
$160M
| $307K | ﹤0.01% |
+1
| New | +$318K |
|
|
CFLT
2135
DELISTED
Confluent
CFLT
| $305K | ﹤0.01% |
+4,000
| New | +$288K |
|
2136
EQT Corp
EQT
$33.3B
| $305K | ﹤0.01% |
+14,000
| New | +$293K |
|
2137
Mistras Group
MG
$484M
| $305K | ﹤0.01% |
41,024
+9,800
| +31% | +$86.2K |
|
2138
Larimar Therapeutics
LRMR
$397M
| $304K | ﹤0.01% |
28,198
-4,700
| -14% | -$52.3K |
|
2139
Zevra Therapeutics
ZVRA
$562M
| $303K | ﹤0.01% |
34,800
+10,500
| +43% | +$93.7K |
|
2140
MarineMax
HZO
$759M
| $301K | ﹤0.01% |
+5,100
| New | +$273K |
|
2141
Tompkins Financial
TMP
$1.43B
| $301K | ﹤0.01% |
+3,600
| New | +$295K |
|
|
CNCE
2142
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $301K | ﹤0.01% |
95,400
+45,900
| +93% | +$153K |
|
|
ITI
2143
DELISTED
Iteris, Inc.
ITI
| $299K | ﹤0.01% |
74,800
+23,800
| +47% | +$115K |
|
2144
BayCom
BCML
$329M
| $298K | ﹤0.01% |
15,900
-8,400
| -35% | -$158K |
|
2145
Orthofix Medical
OFIX
$477M
| $298K | ﹤0.01% |
9,600
+2,426
| +34% | +$81.1K |
|
|
ALLK
2146
DELISTED
Allakos
ALLK
| $296K | ﹤0.01% |
30,200
-5,200
| -15% | -$426K |
|
2147
Cabaletta Bio
CABA
$437M
| $296K | ﹤0.01% |
78,100
+38,000
| +95% | +$405K |
|
|
SYRS
2148
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $295K | ﹤0.01% |
9,060
-8,210
| -48% | -$332K |
|
2149
Ligand Pharmaceuticals
LGND
$5.76B
| $293K | ﹤0.01% |
+3,046
| New | +$281K |
|
|
UCTT
2150
Ultra Clean Holdings
UCTT
$3.73B
| $293K | ﹤0.01% |
5,100
-28,800
| -85% | -$1.5M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, Two Sigma Advisers held 2,910 positions worth $39.9B, up 3.5% from $38.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Two Sigma Advisers's Q4 2021 filing shows 487 new, 855 increased, 1,229 reduced and 318 closed positions. Its largest new stake was NVIDIA: 12,564,000 shares worth $370M. The largest sale was Qualcomm, an estimated $461M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Two Sigma Advisers's largest Q4 2021 buy was NVIDIA: 12,564,000 shares worth $370M.
- Two Sigma Advisers added most to Tesla in Q4 2021, an estimated $379M increase.
- Two Sigma Advisers's biggest Q4 2021 reduction was Qualcomm, cutting an estimated $461M.
- Two Sigma Advisers fully exited Snap in Q4 2021, selling an estimated $379M.
- Two Sigma Advisers's ten largest holdings make up 13% of its $39.9B portfolio in Q4 2021.
- Two Sigma Advisers opened 487 new positions and closed 318 in Q4 2021.
- Two Sigma Advisers's portfolio value rose 3.5% quarter-over-quarter to $39.9B.
Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.